Escalating costs associated with managing their own practice coupled with burdensome insurer policies and regulatory requirements are some of the factors driving physicians to seek employment in other practice settings, according to a new report released by the AHA. The report also sheds light on commercial insurer-acquisition of physician practices and the magnitude of these deals. 
 
“Despite efforts to paint hospitals and health systems as the sole cause of physician practice pattern changes, the truth is that commercial insurer policies, such as prior authorization, are creating unworkable environments forcing physicians to prioritize administrative duties over caring for patients,” the report notes.  
 
Among other findings, the report cites data from a recent survey of physicians conducted by Morning Consult on behalf of the AHA that showed the overwhelming majority (94%) of physicians think it has become more financially and administratively difficult to operate a practice, and 84% of employed physicians reported that the administrative burden from commercial health insurers and government insurance programs had an impact on their employment decision.

Related News Articles

Headline
The AHA today participated in a panel discussion during a conference hosted by The Capitol Forum on the impact of insurer vertical integration. Molly Smith,…
Headline
The Department of Health and Human Services Office of Inspector General yesterday issued an alert warning of marketing schemes by certain Medicare Advantage…
Headline
The Department of Health and Human Services Dec. 11 published a final rule implementing provisions related to the Trusted Exchange Framework and Common…
Headline
The Congressional Budget Office Dec. 5 informed Congress that 2.2 million consumers would lose their health insurance in 2026 if enhanced premium subsidies are…
Headline
A $2.8 billion settlement from Blue Cross Blue Shield to health care providers resolving a 12-year antitrust lawsuit received preliminary approval yesterday…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…